Emerging Biomarkers and Innovative Therapeutic Strategies in Diabetic Kidney Disease: A Pathway to Precision Medicine
Diabetes mellitus (DM) has emerged as the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) globally in recent years. Diabetic nephropathy (DN), or diabetic kidney disease (DKD) that occurs as a direct consequence of DM, has complex pathophysiological mechanisms, s...
Saved in:
| Main Authors: | Sahana Shetty, Renuka Suvarna, Avivar Awasthi, Mohan V. Bhojaraja, Joseph M. Pappachan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-04-01
|
| Series: | Diagnostics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2075-4418/15/8/973 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
New insights on microRNAs in diabetic nephropathy: potential biomarkers for diagnosis and therapeutic targets
by: Elena Sergeevna Kamyshova, et al.
Published: (2017-05-01) -
Early Detection of Diabetic Nephropathy Based on Urinary and Serum Biomarkers: An Updated Systematic Review
by: Farzaneh Karimi, et al.
Published: (2024-10-01) -
Research progress on biomarkers of diabetic nephropathy
by: ZHAO Qingqing, CHENG Xiaoliang
Published: (2025-04-01) -
Research progress on biomarkers of progression of diabetic nephropathy
by: WANG Zi-yi, et al.
Published: (2020-01-01) -
Urinary transferrin as an early biomarker of diabetic nephropathy
by: Terzić Brankica, et al.
Published: (2019-01-01)